13F HOLDINGS REPORT
BML Capital Management, LLC
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0001754960-23-000073
Total Value
$104.7M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ABERCROMBIE & FITCH CO | ANF | 571,117 | $13.1M | 12.50% |
| 2 | IMARA INC | 45249V107 | 3,017,774 | $12.3M | 11.79% |
| 3 | TILLYS INC | 886885102 | 1,154,844 | $10.5M | 9.98% |
| 4 | DISC MEDICINE INC | IRON | 500,000 | $9.9M | 9.50% |
| 5 | SPDR SER TR | 78468R663 | 100,000 | $9.1M | 8.74% |
| 6 | PARDES BIOSCIENCES INC | 69945Q105 | 4,867,984 | $8.2M | 7.86% |
| 7 | ELIEM THERAPEUTICS INC | CLYM | 1,825,134 | $6.7M | 6.40% |
| 8 | SATSUMA PHARMACEUTICALS INC | 80405P107 | 6,440,000 | $5.8M | 5.54% |
| 9 | SESEN BIO INC | 817763105 | 8,227,969 | $5.0M | 4.79% |
| 10 | ADVERUM BIOTECHNOLOGIES INC | 00773U108 | 7,067,179 | $4.1M | 3.91% |
| 11 | VERRICA PHARMACEUTICALS INC | VRCA | 1,110,605 | $3.1M | 2.92% |
| 12 | METACRINE INC | 59101E103 | 6,167,458 | $2.8M | 2.64% |
| 13 | ATHIRA PHARMA INC | 04746L104 | 714,763 | $2.3M | 2.16% |
| 14 | ASTROTECH CORP | ASTC | 220,410 | $2.2M | 2.10% |
| 15 | ARCA BIOPHARMA INC | 00211Y506 | 858,256 | $2.0M | 1.94% |
| 16 | RICHARDSON ELECTRS LTD | 763165107 | 95,359 | $2.0M | 1.94% |
| 17 | FORTE BIOSCIENCES INC | FBRX | 1,461,364 | $1.5M | 1.40% |
| 18 | RETRACTABLE TECHNOLOGIES INC | RVP | 668,575 | $1.1M | 1.05% |
| 19 | MILESTONE PHARMACEUTICALS IN | MIST | 180,000 | $712,800 | 0.68% |
| 20 | GRAYBUG VISION INC | 38942Q103 | 1,235,943 | $617,972 | 0.59% |
| 21 | LISATA THERAPEUTICS INC | LSTA | 243,839 | $616,913 | 0.59% |
| 22 | PASSAGE BIO INC | PASG | 337,467 | $465,704 | 0.44% |
| 23 | ADICET BIO INC | ACET | 30,000 | $268,200 | 0.26% |
| 24 | SPRUCE BIOSCIENCES INC | SPRB | 221,830 | $243,436 | 0.23% |
| 25 | ELEVATION ONCOLOGY INC | 28623U101 | 39,963 | $37,965 | 0.04% |